Hepatic and muscle insulin sensitivity were decreased in patients with NASH compared with controls, as demonstrated by reduced suppression of hepatic glucose production and glucose disposal (Gd) rates following insulin infusion. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.